BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 19308293)

  • 1. Upregulated INHBA expression may promote cell proliferation and is associated with poor survival in lung adenocarcinoma.
    Seder CW; Hartojo W; Lin L; Silvers AL; Wang Z; Thomas DG; Giordano TJ; Chen G; Chang AC; Orringer MB; Beer DG
    Neoplasia; 2009 Apr; 11(4):388-96. PubMed ID: 19308293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. INHBA overexpression promotes cell proliferation and may be epigenetically regulated in esophageal adenocarcinoma.
    Seder CW; Hartojo W; Lin L; Silvers AL; Wang Z; Thomas DG; Giordano TJ; Chen G; Chang AC; Orringer MB; Beer DG
    J Thorac Oncol; 2009 Apr; 4(4):455-62. PubMed ID: 19240652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AZGP1 autoantibody predicts survival and histone deacetylase inhibitors increase expression in lung adenocarcinoma.
    Albertus DL; Seder CW; Chen G; Wang X; Hartojo W; Lin L; Silvers A; Thomas DG; Giordano TJ; Chang AC; Orringer MB; Bigbee WL; Chinnaiyan AM; Beer DG
    J Thorac Oncol; 2008 Nov; 3(11):1236-44. PubMed ID: 18978557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibin βA is an independent prognostic factor that promotes invasion via Hippo signaling in non‑small cell lung cancer.
    Zhang Y; Yan S; Li Y; Zhang J; Luo Y; Li P; Yang Y; Li Y; Huang Y; Wang E
    Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34505633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic regulation of vitamin D metabolism in human lung adenocarcinoma.
    Ramnath N; Nadal E; Jeon CK; Sandoval J; Colacino J; Rozek LS; Christensen PJ; Esteller M; Beer DG; Kim SH
    J Thorac Oncol; 2014 Apr; 9(4):473-82. PubMed ID: 24736069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulated INHBA expression is associated with poor survival in gastric cancer.
    Wang Q; Wen YG; Li DP; Xia J; Zhou CZ; Yan DW; Tang HM; Peng ZH
    Med Oncol; 2012 Mar; 29(1):77-83. PubMed ID: 21132402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of INHBA gene expression to outcomes in gastric cancer after curative surgery.
    Oshima T; Yoshihara K; Aoyama T; Hasegawa S; Sato T; Yamamoto N; Akito N; Shiozawa M; Yoshikawa T; Numata K; Rino Y; Kunisaki C; Tanaka K; Akaike M; Imada T; Masuda M
    Anticancer Res; 2014 May; 34(5):2303-9. PubMed ID: 24778035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant hypermethylation and reduced expression of disabled-2 promote the development of lung cancers.
    Xie XM; Zhang ZY; Yang LH; Yang DL; Tang N; Zhao HY; Xu HT; Li QC; Wang EH
    Int J Oncol; 2013 Nov; 43(5):1636-42. PubMed ID: 24002585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of INHBA expression in human colorectal cancer.
    Okano M; Yamamoto H; Ohkuma H; Kano Y; Kim H; Nishikawa S; Konno M; Kawamoto K; Haraguchi N; Takemasa I; Mizushima T; Ikeda M; Yokobori T; Mimori K; Sekimoto M; Doki Y; Mori M; Ishii H
    Oncol Rep; 2013 Dec; 30(6):2903-8. PubMed ID: 24085226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated nuclear CCND1 expression confers an unfavorable prognosis for early stage lung adenocarcinoma patients.
    Xu P; Zhao M; Liu Z; Liu Y; Chen Y; Luo R; Fang W
    Int J Clin Exp Pathol; 2015; 8(12):15887-94. PubMed ID: 26884860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An 8-gene signature, including methylated and down-regulated glutathione peroxidase 3, of gastric cancer.
    Zhang X; Yang JJ; Kim YS; Kim KY; Ahn WS; Yang S
    Int J Oncol; 2010 Feb; 36(2):405-14. PubMed ID: 20043075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibin, beta A regulates the transforming growth factor-beta pathway to promote malignant biological behaviour in colorectal cancer.
    He Z; Liang J; Wang B
    Cell Biochem Funct; 2021 Mar; 39(2):258-266. PubMed ID: 32662905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of SIX3 is associated with clinical outcome in lung adenocarcinoma.
    Mo ML; Okamoto J; Chen Z; Hirata T; Mikami I; Bosco-Clément G; Li H; Zhou HM; Jablons DM; He B
    PLoS One; 2013; 8(8):e71816. PubMed ID: 23977152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of special AT-rich binding protein 1 expression is a marker of poor survival in lung cancer.
    Selinger CI; Cooper WA; Al-Sohaily S; Mladenova DN; Pangon L; Kennedy CW; McCaughan BC; Stirzaker C; Kohonen-Corish MR
    J Thorac Oncol; 2011 Jul; 6(7):1179-89. PubMed ID: 21597389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Significance of
    Katayama Y; Oshima T; Sakamaki K; Aoyama T; Sato T; Masudo K; Shiozawa M; Yoshikawa T; Rino Y; Imada T; Masuda M
    In Vivo; 2017; 31(4):565-571. PubMed ID: 28652421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas.
    Wang J; Zou K; Feng X; Chen M; Li C; Tang R; Xuan Y; Luo M; Chen W; Qiu H; Qin G; Li Y; Zhang C; Xiao B; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
    Mol Cancer; 2017 Oct; 16(1):158. PubMed ID: 29025423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA Hypomethylation Is Associated with the Overexpression of INHBA in Upper Tract Urothelial Carcinoma.
    Kao CC; Chang YL; Liu HY; Wu ST; Meng E; Cha TL; Sun GH; Yu DS; Luo HL
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ZIC1 is silenced and has tumor suppressor function in malignant pleural mesothelioma.
    Cheng YY; Kirschner MB; Cheng NC; Gattani S; Klebe S; Edelman JJ; Vallely MP; McCaughan BC; Jin HC; van Zandwijk N; Reid G
    J Thorac Oncol; 2013 Oct; 8(10):1317-28. PubMed ID: 24457242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stromal LRP1 in lung adenocarcinoma predicts clinical outcome.
    Meng H; Chen G; Zhang X; Wang Z; Thomas DG; Giordano TJ; Beer DG; Wang MM
    Clin Cancer Res; 2011 Apr; 17(8):2426-33. PubMed ID: 21325077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. INHBA is a prognostic predictor for patients with colon adenocarcinoma.
    Li X; Yu W; Liang C; Xu Y; Zhang M; Ding X; Cai X
    BMC Cancer; 2020 Apr; 20(1):305. PubMed ID: 32293338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.